CIDTINE

This brand name is authorized in Nigeria.

Active ingredients

The drug CIDTINE contains one active pharmaceutical ingredient (API):

1	Cimetidine UNII 80061L1WGD - CIMETIDINE
	Cimetidine is a histamine H2-receptor antagonist which rapidly inhibits both basal and stimulated gastric secretion of acid and reduces pepsin output. It is a reversible, competitive antagonist, and is used as an anti-ulcer drug.
	Read more about Cimetidine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-6362	Tablet	CIDTINE TABLETS 400MG TAB 400 mg	CIDTINE TABLETS 400MG A4-6362 CIDTINE TABLETS 400MG CIMETIDINE 400MG POM 1 DANNYFAITH PHARMACY LIMITED, , OSENI STREET, LAWANSON, SURULERE LAGOS JIANGXI XIERKANGTAI PHARMACEUTICAL CO. LTD, NORTH ZONE, HIGH-NEW TECHNOLOGY INDUSTRIAL ZONE, PINGXIANG, JIANGXI, China 2/23/2023 2/22/2028	23/02/2023
A4-8427	Tablet	CIDTINE TABLETS 200MG TAB 200 mg	CIDTINE TABLETS 200MG A4-8427 CIDTINE TABLETS 200MG CIMETIDINE 200MG POM 1 DANNYFAITH PHARMACY LIMITED, , OSENI STREET, LAWANSON, SURULERE LAGOS JIANGXI XIER KANGXI PHARM CO. LTD, NORTH ZONE HIGH NEW TECH IND ZONE PINGXIANG JIANGXI CHINA, China 2/23/2023 2/22/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BA01	Cimetidine	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BA H2-receptor antagonists
Discover more medicines within A02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-6362, A4-8427